chronic bronchitis


Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
Related to chronic bronchitis: emphysema, Acute bronchitis
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Words related to chronic bronchitis

a form of bronchitis characterized by excess production of sputum leading to a chronic cough and obstruction of air flow

References in periodicals archive ?
University of Arizona researchers assessed whether an active asthma diagnosis is a predictor of a future diagnosis of emphysema, chronic bronchitis, or COPD (emphysema and/or chronic bronchitis and pulmonary function test results less than 80 percent of predicted).
Chronic obstructive pulmonary disease (COPD)* patients with acute exacerbations of chronic bronchitis (AECB) who took the antibiotic Avelox(R) (moxifloxacin HCl) for five days experienced significantly faster recovery compared to patients who took Biaxin(R)(clarithromycin) or Augmentin(R) (amoxicillin/clavulanate) for 10 days.
FACTIVE is currently approved by the FDA for the five-day treatment of acute exacerbations of chronic bronchitis (AECB) and the seven-day treatment of CAP.
March 8 /PRNewswire/ -- A new study shows patients with acute exacerbations of chronic bronchitis (AECB) who took a five-day course of the antibiotic Avelox (moxifloxacin HCl) achieved a greater clinical cure rate than patients who took a seven-day course of the antibiotics most commonly prescribed to treat AECB, such as clarithromycin, amoxicillin and cefuroxime-axetil.
Food and Drug Administration (FDA) has approved a new treatment for a serious lung disease that affects millions of Americans -- chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis.
Patients with COPD include those with chronic bronchitis, asthmatic bronchitis, and emphysema.
Food and Drug Administration (FDA) has approved Advair Diskus 250/50 as a new treatment for a serious lung disease that affects millions of Americans - chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis.
The Company markets two products: FACTIVE(R) (gemifloxacin mesylate) tablets, approved by the FDA for the treatment of acute bacterial exacerbations of chronic bronchitis and community-acquired pneumonia of mild to moderate severity and ANTARA(R) 130 mg (fenofibrate) capsules, FDA-approved for the adjunct treatment of hypercholesterolemia (high blood cholesterol) and hypertriglyceridemia (high triglycerides) in combination with diet.
today announced that it will discontinue the development of INS365 Respiratory for chronic bronchitis, based on a recent portfolio review and a continued focus on higher priority programs including dry eye and allergic rhinitis.
Food and Drug Administration (FDA) on October 6, 2006, BROVANA is a long-term, twice-daily (morning and evening), maintenance treatment of bronchoconstriction in patients with COPD, including chronic bronchitis and emphysema.
Food and Drug Administration (FDA) approved its New Drug Application (NDA) for BROVANA([TM]) (arformoterol tartrate) Inhalation Solution 15 mcg (micrograms) as a long-term, twice-daily (morning and evening), maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
Pfizer Mexico is promoting FACTIVE-5 in Mexico for the five-day treatment of acute bacterial exacerbations of chronic bronchitis (AECB), acute bacterial sinusitis (ABS) and community-acquired pneumonia (CAP).
13 /PRNewswire/ -- The FDA has just approved a new antibiotic to treat flare-ups of chronic bronchitis.
Full browser ?